Osmind Raises $40M Series B Round Led by DFJ Growth to Expand Platform for Breakthrough Mental Health Research and Treatment May 10, 2022 San Francisco Biotechnology Network News News Comments Off on Osmind Raises $40M Series B Round Led by DFJ Growth to Expand Platform for Breakthrough Mental Health Research and Treatment SAN FRANCISCO--(BUSINESS WIRE)--Osmind raises $40M Series B round led by DFJ Growth to expand platform for breakthrough mental health research and treatment. Click to view original post